Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.54 |
| ▸ | ACACB | O00763 | 16/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7752956 | 0.86 | ACACB (0.55) | ACACB | |
| SCHEMBL26172590 | 0.84 | ALDH1A1 (0.53) | ALDH1A1 | |
| SCHEMBL13780264 | 0.83 | PARP10 (0.54) | PARP10ACACBALDH1A1 | |
| SCHEMBL27928968 | 0.83 | ACACB (0.52) | ACACB | |
| SCHEMBL13663555 | 0.83 | PARP10 (0.54) | PARP10ACACBALDH1A1 | |
| SCHEMBL933857 | 0.83 | LDHA (0.61) | PARP10ACACBALDH1A1 | |
| SCHEMBL13780265 | 0.82 | ACACB (0.57) | ACACB | |
| SCHEMBL11445970 | 0.81 | MAOB (0.60) | PARP10 | |
| SCHEMBL23643109 | 0.80 | EPHX1 (0.50) | ACACBALDH1A1 | |
| SCHEMBL13814063 | 0.79 | ACACB (0.50) | PARP10ACACBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090176967-A1 | Conjugation of FVII | NOVO NORDISK HEALTHCARE A/G (CH) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176967-A1 | Conjugation of FVII | F13B, F13A1, FGB | PARP10 2011/4885ACACB 2868/4885ALDH1A1 4528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.